These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 36110123)
1. Development of a Clinical Prognostic Model for Metabolism-Related Genes in Squamous Lung Cancer and Correlation Analysis of Immune Microenvironment. Zhuang Z; Gao C Biomed Res Int; 2022; 2022():6962056. PubMed ID: 36110123 [TBL] [Abstract][Full Text] [Related]
2. A robust signature associated with patient prognosis and tumor immune microenvironment based on immune-related genes in lung squamous cell carcinoma. Zhou H; Zhang H; Shi M; Wang J; Huang Z; Shi J Int Immunopharmacol; 2020 Nov; 88():106856. PubMed ID: 32777677 [TBL] [Abstract][Full Text] [Related]
3. Significance of Lin H; Wang J; Shi Q; Wu M PeerJ; 2024; 12():e17338. PubMed ID: 38708353 [TBL] [Abstract][Full Text] [Related]
4. Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma. Lei K; Liang R; Tan B; Li L; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M Oxid Med Cell Longev; 2023; 2023():6811625. PubMed ID: 36703911 [TBL] [Abstract][Full Text] [Related]
5. Development and validation of a novel immune-related prognostic model in lung squamous cell carcinoma. Liu Z; Wan Y; Qiu Y; Qi X; Yang M; Huang J; Zhang Q Int J Med Sci; 2020; 17(10):1393-1405. PubMed ID: 32624696 [No Abstract] [Full Text] [Related]
6. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719 [TBL] [Abstract][Full Text] [Related]
7. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis. Fan T; Lu Z; Liu Y; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J Front Immunol; 2021; 12():665407. PubMed ID: 34177903 [TBL] [Abstract][Full Text] [Related]
8. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Li Y; Zheng P; Zhan X Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015 [TBL] [Abstract][Full Text] [Related]
9. Construction of a predictive model for immunotherapy efficacy in lung squamous cell carcinoma based on the degree of tumor-infiltrating immune cells and molecular typing. Yang L; Wei S; Zhang J; Hu Q; Hu W; Cao M; Zhang L; Wang Y; Wang P; Wang K J Transl Med; 2022 Aug; 20(1):364. PubMed ID: 35962453 [TBL] [Abstract][Full Text] [Related]
10. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma. Yang Q; Gong H; Liu J; Ye M; Zou W; Li H Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696 [TBL] [Abstract][Full Text] [Related]
11. Prediction of Tumor Microenvironment Characteristics and Treatment Response in Lung Squamous Cell Carcinoma by Pseudogene OR7E47P-related Immune Genes. Zhao YQ; Zhang HH; Wu J; Li L; Li J; Zhong H; Jin Y; Lei TY; Zhao XY; Xu B; Song QB; He J Curr Med Sci; 2023 Dec; 43(6):1133-1150. PubMed ID: 38015361 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Glycolysis-Related Genes in Lung Squamous Cell Carcinoma. Kadasah SF Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256214 [TBL] [Abstract][Full Text] [Related]
13. System analysis of Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116 [TBL] [Abstract][Full Text] [Related]
14. Classification of the immune microenvironment associated with 12 cell death modes and construction of a prognostic model for squamous cell lung cancer. Bin Y; Ding P; Liu L; Tong F; Dong X J Cancer Res Clin Oncol; 2023 Sep; 149(11):9051-9070. PubMed ID: 37169931 [TBL] [Abstract][Full Text] [Related]
15. Characterization of prognostic signature related with twelve types of programmed cell death in lung squamous cell carcinoma. Li S; Ding B; Weng D J Cardiothorac Surg; 2024 Oct; 19(1):569. PubMed ID: 39354528 [TBL] [Abstract][Full Text] [Related]
16. Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma. Kim A; Lim SM; Kim JH; Seo JS Front Immunol; 2021; 12():598671. PubMed ID: 33717076 [TBL] [Abstract][Full Text] [Related]
17. Identification of RNMT as an immunotherapeutic and prognostic biomarker: From pan-cancer analysis to lung squamous cell carcinoma validation. Huang S; Tan C; Zheng J; Huang Z; Li Z; Lv Z; Chen W; Chen M; Yuan X; Chen C; Yan Q Immunobiology; 2024 Sep; 229(5):152836. PubMed ID: 39018675 [TBL] [Abstract][Full Text] [Related]
18. Identification of Clinical Prognostic Regulators and Analysis of Ferroptosis-Related Signatures in the Tumor Immune Microenvironment in Lung Squamous Cell Carcinoma. Wang W; Cui G; Zhao S Dis Markers; 2023; 2023():9155944. PubMed ID: 36845013 [TBL] [Abstract][Full Text] [Related]
19. Establishment of a prognostic model toward lung squamous cell carcinoma based on m Wang Y; Liu Y; Wang R; Cao F; Guan Y; Chen Y; An B; Qin S; Yao S Physiol Genomics; 2023 Oct; 55(10):427-439. PubMed ID: 37575065 [TBL] [Abstract][Full Text] [Related]
20. A novel model based on liquid-liquid phase separation-Related genes correlates immune microenvironment profiles and predicts prognosis of lung squamous cell carcinoma. Zhuge L; Zhang K; Zhang Z; Guo W; Li Y; Bao Q J Clin Lab Anal; 2022 Jan; 36(1):e24135. PubMed ID: 34799879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]